Johnson & Johnson to Pay $5.5 Billion to Settle Talc Powder Lawsuits
- Johnson & Johnson has agreed to pay $5.5 billion to settle lawsuits alleging that its talc-based baby powder caused cancer, according to reporting from LSM.
- Plaintiffs in these cases argued that the talc used in the products was contaminated with asbestos, a known carcinogen, and that the company failed to warn consumers about...
- Johnson & Johnson has consistently denied that its talc products contain asbestos or cause cancer.
Johnson & Johnson has agreed to pay $5.5 billion to settle lawsuits alleging that its talc-based baby powder caused cancer, according to reporting from LSM. The settlement aims to resolve thousands of claims from plaintiffs who assert that the company’s powder contained asbestos, leading to ovarian cancer and mesothelioma.
The agreement follows years of litigation in U.S. courts. Plaintiffs in these cases argued that the talc used in the products was contaminated with asbestos, a known carcinogen, and that the company failed to warn consumers about these risks.
Johnson & Johnson has consistently denied that its talc products contain asbestos or cause cancer. Despite these denials, the company has faced numerous jury verdicts and massive payouts in individual cases, prompting the move toward a global settlement to end the legal uncertainty.
Financial Terms and Legal Strategy
The $5.5 billion sum is designated to settle the vast majority of pending talc-related claims. This financial commitment is part of a broader strategy by the company to manage the liability associated with its baby powder line through the bankruptcy court system, a move designed to consolidate all current and future claims into a single resolution.
By settling these claims, the company seeks to avoid the unpredictability of individual trials, where some juries had previously awarded plaintiffs hundreds of millions of dollars in damages.
Product Changes and Market Impact
The legal challenges coincided with a shift in the company’s product offerings. Johnson & Johnson transitioned its baby powder from a talc-based formula to a cornstarch-based formula globally. This change was implemented to address consumer concerns and reduce the risk of future litigation related to talc contamination.
The company previously stopped selling talc-based baby powder in North America in 2020 and completed the global transition to cornstarch by 2023.
Health Allegations and Company Response
The core of the legal dispute centers on the presence of asbestos in talc deposits. Because talc and asbestos naturally occur together in the earth, critics and plaintiffs’ attorneys argued that the mining process failed to remove all asbestos fibers, which then remained in the finished powder.
Johnson & Johnson has maintained that its talc is safe and that independent tests have not found asbestos in its products. The company argues that the scientific evidence does not support a causal link between the use of its talc-based powder and the development of ovarian cancer.
